Disopod Dry Syrup

Composition:

DISOPOD 50 DRY SYRUP: Each 5ml contains Cefpodoxime 50mgin 30ml pack.

DISOPOD 100 DRY SYRUP: Each 5ml contains Cefpodoxime 100mg in 30ml pack.

Formulation: Dry Syrup

Flavour:

Disopod 50 – Orange, Pineapple and Peppermint ,

Disopod 100 – Orange, Pineapple and Peppermint

Category:

Therapy / Class: Antibacterial/Third-Generation Cephalosporin Antibiotic

Spectrum of Coverage

Gram-positive bacteria:

  • Staphylococcus aureus (methicillin-susceptible strains, including those producing penicillinases)
  • Staphylococcus saprophyticus
  • Streptococcus pneumoniae (excluding penicillin-resistant isolates)
  • Streptococcus pyogenes

Gram-negative bacteria:

  • Escherichia coli
  • Klebsiella pneumoniae
  • Proteus mirabilis
  • Haemophilus influenzae (including beta-lactamase producing isolates)
  • Moraxella catarrhalis
  • Neisseria gonorrhoeae (including penicillinase-producing isolates)

Mechanism of Action:

Shows bactericidal action by inhibition of bacterial cell wall synthesis. Active against some beta-lactamases, both penicillinasesand cephalosporinases, of Gram-negative and Gram-positive bacteria

Indications:

  • Acute otitis media
  • Pharyngitis and/or tonsillitis
  • Community-acquired pneumonia
  • Acute bacterial exacerbation of chronic bronchitis
  • Uncomplicated skin and skin structure infections
  • Acute maxillary sinusitis
  • Uncomplicated urinary tract infections

Dosage & Administration:

Infants and Pediatric Patients (age 2 months through 12 years)
Type of InfectionTotal Daily DoseDose FrequencyDuration
Acute otitis media10 mg/kg/day (Max 400 mg/day)5 mg/kg Q 12 h (Max 200 mg/dose)5 days
Pharyngitis and/or tonsillitis10 mg/kg/day (Max 200 mg/day)5 mg/kg/dose Q 12 h (Max 100 mg/dose)5 to 10 days
Acute maxillary sinusitis10 mg/kg/day (Max 400 mg/day)5 mg/kg Q 12 hours (Max 200 mg/dose)10 days

HOW SUPPLIED:
DISOPOD 50 DRY SYRUP is Dry Syrup available as 30ml packs with Sterile Water
DISOPOD 100 DRY SYRUP is Dry Syrup available as 30ml packs with Sterile Water

References:

  • J Clin DiagnRes . 2017 Jun;11(6):FC01-FC04.
  • Journal of Antimicrobial Chemotherapy (2002) 50, Topic T1, 23–27
  • Drugs Context. 2020; 9: 2020-9-3.
error: Content is protected !!